Shiru, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Shiru, Inc. - overview
Established
2019
Location
Berkeley, CA, US
Primary Industry
Biotechnology
About
Shiru, Inc. is a US-based company specializing in innovative ingredient solutions that promote sustainability across food, personal care, and agriculture sectors, focusing on natural proteins to enhance product functionality. Founded in 2019 and headquartered in Berkeley, US, Shiru, Inc. develops sustainable ingredient solutions.
The company has undergone no significant pivots in its core business strategy. Jasmin Hume, the founder and current CEO, drives the company's vision. Shiru successfully completed its Series B funding round, raising USD 16. 00 mn on November 12, 2024, led by S2G Ventures along with CPT Capital, Lux Capital, Meach Cove Capital, and Nourish Ventures.
The total funds raised by Shiru amount to USD 16. 00 mn, with a current company valuation of USD 30. 20 mn. Shiru specializes in innovative ingredient solutions across the food, personal care, and agriculture sectors, with a focus on natural proteins that enhance product functionality while promoting sustainability.
Their offerings include OleoPro™, a structured fat alternative to replicate animal fat properties, and uPro™, a texturizing protein for diverse food applications. Shiru's proprietary Flourish™ platform expedites ingredient discovery, transitioning products from concept to market readiness within 1-2 years, significantly reducing the traditional discovery period. Their products target manufacturers and brands seeking clean-label, high-performance alternatives, actively marketed in North America and Europe. Shiru generates revenue through partnerships with businesses seeking to commercialize their innovative ingredients.
The model operates on a B2B basis, with manufacturers and product developers engaging Shiru for products like OleoPro™ and uPro™, alongside other clean-label alternatives. Pricing reflects the specialized nature of these offerings and is customized based on client needs. This collaborative approach with companies that integrate Shiru's ingredients into final products bolsters their revenue model in a competitive landscape. In November 2024, Shiru, Inc.
raised USD 16. 00 mn in Series B funding to support its growth and expansion plans. The company aims to develop new products and expand into specific markets, although detailed release dates or targeted regions have not been disclosed. Recent funding will bolster these initiatives, allowing Shiru to enhance its ingredient offerings and reach broader markets.
Current Investors
Lux Capital, Y Combinator, S2G Ventures
Primary Industry
Biotechnology
Sub Industries
Health Foods & Nutritional Supplements, Bioinformatics
Website
www.shiru.com
Verticals
Artificial Intelligence, Manufacturing
Company Stage
Series B
Total Amount Raised
Subscriber access only

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.